ArticleIndian journal of microbiology2025
Invasive Fungal Infections in Acute Decompensation of Cirrhosis: Epidemiology, Predictors of 28-Day Mortality, and Outcomes.
Article in Indian journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute-on-chronic liver failure (ACLF) is a severe syndrome characterized by acute decompensation (AD), organ failures, and high short-term mortality. Once patients with AD or ACLF have complications with invasive fungal infection (IFI), the mortality rate further increases. In this study, a total of 1636 patients with AD of cirrhosis diagnosed between January 2008 and December 2017 were enrolled in the Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Of the 1636 patients with AD of cirrhosis, 191 were complicated by IFI and their epidemiological characteristics were investigated. Cox proportional hazards regression was performed to analyze the factors impacting a 28-day survival in AD or ACLF with IFI. The findings indicated that the incidence of IFI in patients with AD of cirrhosis was 13.5%; the most common source of infection is pneumonia; the most common strain of fungi was
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.